Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BLM-07D1 by Systimmune for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer): Likelihood of Approval
BLM-07D1 is under clinical development by Systimmune and currently in Phase III for Human Epidermal Growth Factor Receptor 2 Positive...
BLM-07D1 by Systimmune for Metastatic Transitional (Urothelial) Tract Cancer: Likelihood of Approval
BLM-07D1 is under clinical development by Systimmune and currently in Phase I for Metastatic Transitional (Urothelial) Tract Cancer. According to...
BLM-07D1 by Systimmune for Metastatic Ovarian Cancer: Likelihood of Approval
BLM-07D1 is under clinical development by Systimmune and currently in Phase I for Metastatic Ovarian Cancer. According to GlobalData, Phase...
BLM-07D1 by Systimmune for Endometrial Cancer: Likelihood of Approval
BLM-07D1 is under clinical development by Systimmune and currently in Phase I for Endometrial Cancer. According to GlobalData, Phase I...
BLM-07D1 by Systimmune for Cervical Cancer: Likelihood of Approval
BLM-07D1 is under clinical development by Systimmune and currently in Phase I for Cervical Cancer. According to GlobalData, Phase I...
BLM-07D1 by Systimmune for Gynecological Cancer: Likelihood of Approval
BLM-07D1 is under clinical development by Systimmune and currently in Phase II for Gynecological Cancer. According to GlobalData, Phase II...